SAN FRANCISCO--(BUSINESS WIRE)--Unlearn ®, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller, faster studies, today ...
Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...
Collaboration will leverage Unlearn's AI-powered digital twins in QurAlis' clinical trials for their leading ALS therapies CAMBRIDGE, Mass. and SAN FRANCISCO, June 27, 2023 /PRNewswire/ -- QurAlis ...
Unlearn seems to have retained a lesson or two about fundraising: The digital twin developer announced this week that it has raised another $50 million, echoing its last funding round two years ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback